Skip to Content

500/20 (Vimovo esomeprazole 20 mg / naproxen 500 mg)

Generic Name: esomeprazole/naproxen

Pill imprint 500/20 has been identified as Vimovo esomeprazole 20 mg / naproxen 500 mg.

Vimovo is used in the treatment of ankylosing spondylitis; osteoarthritis; rheumatoid arthritis; nsaid-induced ulcer prophylaxis and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Vimovo esomeprazole 20 mg / naproxen 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Vimovo esomeprazole 20 mg / naproxen 500 mg 500/20
Vimovo
Generic Name:
esomeprazole/naproxen
Imprint:
500/20
Strength:
esomeprazole 20 mg / naproxen 500 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
N - Not a controlled drug
Manufacturer:
AstraZeneca Pharmaceuticals
National Drug Code (NDC):
00186-0520
Inactive Ingredients:
carnauba wax
silicon dioxide
croscarmellose sodium
ferric oxide yellow
glyceryl monostearate
hypromelloses
magnesium stearate
methacrylic acid
methylparaben
polysorbate 80
polyethylene glycol
povidone
propylparaben
titanium dioxide
triethyl citrate
ferrosoferric oxide
polydextrose

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide